In the news

January 27, 2020

Getting cancer drugs to the brain is difficult – but a new ‘road map’ might make it easier

The human brain has some remarkable capabilities – including the ability to block cancer drugs from effectively reaching cancer cells in the brain. The greatest obstacle when it comes to treating cancer that has spread to the brain is the blood-brain barrier, the brain’s natural defense mechanism that is a collection of blood vessels that can filter out what goes in and out of the brain

January 10, 2020

Synthetic neurons project offers platform for disease treatment, further brain research

The body can recover from many things, but the damage caused by Parkinson’s disease isn’t one of them. No cure exists for Parkinson’s, which 1 million people in the U.S. are expected to be living with by 2020. But an outright cure isn’t the primary objective of research by Chongli Yuan, a Purdue University chemical engineering professor and leader of Purdue’s section of a multidisciplinary team studying the possibility of building synthetic neuron cells

December 12, 2019

An engineering approach to reduce the pain of chemotherapy

A study published in the American Journal of Managed Care states that the number of patients requiring first-line chemotherapy is expected to increase by more than 50%, from 9.8 million to 15 million, from 2018 to 2040. One of the most common side effects for those undergoing chemotherapy is peripheral neuropathy, a set of symptoms caused by damage to nerves that control the sensations and movements of arms, legs, hands and feet. The issue can be so intense in children that they can have trouble with simple handwriting and walking.

November 11, 2019

Purdue University Chemistry Professor Creates Device To Combat Cancer Drug Cost

A Purdue University professor is working to resolve the issue of cancer drug shortages. This could mean more money in the pocket for cancer patients and their families.

3D body mapping could identify, treat organs, cells damaged from medical conditions

WEST LAFAYETTE, Ind. – Medical advancements can come at a physical cost. Often following diagnosis and treatment for cancer and other diseases, patients’ organs and cells can remain healed but damaged from the medical condition.

August 15, 2018

Purdue Researchers use High End Imaging to Study Patterns of Gene Expression in Developing Plants

A recent paper in Science by Purdue researcher Yun Zhou and colleagues provides new insight into the way plants control stem cell activity during growth. Researchers used a confocal microscope located in Bindley's Imaging Core Facility to confirm that a small family of HAIRY MERISTEM genes helps regulate spatial patterns of gene expression in Arabidopsis stem cells.

August 14, 2018

Staff Profile: Christina Ferreira

Bindley's Metabolite Profiling Facility (MPF) provides state of the art technologies for analysis of small biological molecules. As a lipidomics specialist, Christina Ferreira works with faculty to develop fast, exploratory methods for lipid analysis.

Disease Diagnostic Inventor’s Challenge

Bindley scientists were part of collaborative teams awarded funding from the Institute of Inflammation, Immunology, and Infectious Disease to develop new diagnostic technologies. Team members included clinicians, biologists, and engineers. Bindley scientists will collaborate in the development of new techniques to treat drug resistant bacteria and diagnostics for atopic dermatits for veterinary and human applications.

New 3D disease-on-a-chip technique provides better screening tools for agressive cancers

Purdue University researchers have developed a technique they hope will provide valuable information about the growth of certain cancers and the ability of drugs to fight them.

Key Factor in Development of Parkinson’s Diesease Identified

A molecule has been identified that appears to play an important role in the development of Parkinson's disease, a debilitating disease that affects millions of people around the world. The discovery could lead to therapies, potentially including drugs currently on the market, and it could facilitate earlier diagnosis and prevention of the neurological disorder.